Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Smith

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Journal of Esthetic and Restorative Dentistry : Official Publication of the American Academy of Esthetic Dentistry ... [Et Al.]|February 26, 2004
Use of yellow plastic food wrap to retard composite resin polymerizationMark S Hagge, Scott C Di Lorenzo, James S Lindemuth, et al.
Platelets|November 28, 2017
Development of a high-yield expression and purification system for platelet factor 4Angela Huynh, Donald M Arnold, Jane C Moore, et al.
Current Medical Research and Opinion|April 2, 2005
Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipidsAnnie H Shinn, Sian M Carr-Lopez, James W Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|January 2, 2021
A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopeniaJulian G Rubino, Donald M Arnold, Theodore E Warkentin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2019
The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic testJohn R Vrbensky, Joyce E Moore, Donald M Arnold, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodiesAndreas Koster, Ishac Nazy, Ingvild E Birschmann, et al.
Chest|January 13, 2018
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release AssayTheodore E Warkentin, Donald M Arnold, John G Kelton, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Molecular architecture and platelet-activating properties of small immune complexes assembled on intact heparin and their possible involvement in heparin-induced thrombocytopeniaYang Yang, Yi Du, Daniil Ivanov, et al.
American Journal of Hematology|October 18, 2019
Serotonin-release assay-negative heparin-induced thrombocytopeniaTheodore E Warkentin, Ishac Nazy, Jo-Ann I Sheppard, et al.
Thrombosis Research|August 14, 2020
The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopeniaAngela Huynh, Donald M Arnold, James W Smith, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Journal of Esthetic and Restorative Dentistry : Official Publication of the American Academy of Esthetic Dentistry ... [Et Al.]|February 26, 2004
Use of yellow plastic food wrap to retard composite resin polymerizationMark S Hagge, Scott C Di Lorenzo, James S Lindemuth, et al.
Platelets|November 28, 2017
Development of a high-yield expression and purification system for platelet factor 4Angela Huynh, Donald M Arnold, Jane C Moore, et al.
Current Medical Research and Opinion|April 2, 2005
Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipidsAnnie H Shinn, Sian M Carr-Lopez, James W Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|January 2, 2021
A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopeniaJulian G Rubino, Donald M Arnold, Theodore E Warkentin, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2019
The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic testJohn R Vrbensky, Joyce E Moore, Donald M Arnold, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodiesAndreas Koster, Ishac Nazy, Ingvild E Birschmann, et al.
Chest|January 13, 2018
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release AssayTheodore E Warkentin, Donald M Arnold, John G Kelton, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Molecular architecture and platelet-activating properties of small immune complexes assembled on intact heparin and their possible involvement in heparin-induced thrombocytopeniaYang Yang, Yi Du, Daniil Ivanov, et al.
American Journal of Hematology|October 18, 2019
Serotonin-release assay-negative heparin-induced thrombocytopeniaTheodore E Warkentin, Ishac Nazy, Jo-Ann I Sheppard, et al.
Thrombosis Research|August 14, 2020
The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopeniaAngela Huynh, Donald M Arnold, James W Smith, et al.
Pageof 7